IP Library Granted Patent US 7,723,568
Granted Patent B2
US 7,723,568 · App. 11/545,106 · Granted May 25, 2010

Engineered miRNA precursors for suppressing target gene expression in plants

Assignee: Monsanto Technology LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,568
App. No.
11/545,106
Granted
May 25, 2010
Kind
B2
Abstract

The present invention provides molecular constructs and methods for use thereof, including constructs including heterologous miRNA recognition sites, constructs for gene suppression including a gene suppression element embedded within an intron flanked on one or on both sides by non-protein-coding sequence, constructs containing engineered miRNA or miRNA precursors, and constructs for suppression of production of mature microRNA in a cell. Also provided are transgenic plant cells, plants, and seeds containing such constructs, and methods for their use. The invention further provides transgenic plant cells, plants, and seeds containing recombinant DNA for the ligand-controlled expression of a target sequence, which may be endogenous or exogenous. Also disclosed are novel miRNAs and miRNA precursors from crop plants including maize and soy.

Claims (37)

1. A recombinant DNA construct comprising a transcribable engineered miRNA precursor designed to suppress a target sequence,

wherein said miRNA precursor comprises a fold-back structure comprising a stem with the mismatches found in the miRNA precursor formed from SEQ ID No. 228 and a loop region of the fold-back structure of the miRNA precursor formed from SEQ ID No. 228.

2. A method to suppress expression of a target sequence in a plant cell, comprising transcribing in a plant cell the recombinant DNA construct of claim 1 , whereby expression of said target sequence is suppressed relative to its expression in the absence of transcription of said recombinant DNA construct.

3. A transgenic seed having in its genome the recombinant DNA construct of claim 1 .

4. A transgenic plant grown from the transgenic seed of claim 3 .

5. The transgenic seed of claim 3 , wherein said transgenic seed has modified primary metabolite, trace element, carotenoid, vitamin, or secondary metabolite composition, or improved storage or processing quality.

6. The transgenic plant of claim 4 , wherein said transgenic plant has at least one altered trait, relative to a plant lacking said recombinant DNA construct, selected from the group of traits consisting of:

(a) improved abiotic stress tolerance;

(b) improved biotic stress tolerance;

(c) improved resistance to a pest or pathogen of said plant;

(d) modified primary metabolite composition;

(e) modified secondary metabolite composition;

(f) modified trace element, carotenoid, or vitamin composition;

(g) improved yield;

(h) improved ability to use nitrogen or other nutrients;

(i) modified agronomic characteristics;

(j) modified growth or reproductive characteristics; and

(k) improved harvest, storage, or processing quality.

7. A transgenic plant cell having in its genome a recombinant DNA construct comprising a transcribable engineered miRNA precursor designed to suppress a target sequence,

wherein said miRNA precursor comprises a fold-back structure comprising a stem with the mismatches found in the miRNA precursor formed from SEQ ID No. 228 and a loop region of the fold-back structure of the miRNA precursor formed from SEQ ID No. 228.

8. The transgenic plant cell of claim 7 , wherein said recombinant DNA construct further comprises a gene expression element for expressing at least one gene of interest.

9. A regenerated transgenic plant or seed prepared from the transgenic plant cell of claim 7 .

10. A method of providing at least one altered plant tissue, comprising:

(a) providing a transgenic plant comprising a regenerated plant prepared from a transgenic plant cell of claim 7 , or a progeny plant of said regenerated plant; and

(b) transcribing said recombinant DNA construct in at least one tissue of said transgenic plant, whereby an altered trait in said at least one tissue results, relative to tissue wherein said recombinant DNA construct is not transcribed, said altered trait being selected from:

(i) improved abiotic stress tolerance;

(ii) improved biotic stress tolerance;

(iii) improved resistance to. a pest or pathogen of said plant;

(iv) modified primary metabolite composition;

(v) modified secondary metabolite composition;

(vi) modified trace element, carotenoid, or vitamin composition;

(vii) improved yield;

(viii) improved ability to use nitrogen or other nutrients;

(ix) modified agronomic characteristics;

(x) modified growth or reproductive characteristics; and

(xi) improved harvest, storage, or processing quality.

11. The method of claim 10 , wherein said transgenic plant is a transgenic crop plant.

Continuity (5)
Division 1130374500 · Dec 15, 2005
Provisional Application 6072000500 · Sep 24, 2005
Provisional Application 6072610600 · Oct 13, 2005
Provisional Application 6073652500 · Nov 14, 2005
Related Publication 20070089196A1 · Apr 19, 2007